T(1) /T(2) ratio from 3T MRI improves multiple sclerosis cortical lesion contrast

3T磁共振成像的T1/T2比值可提高多发性硬化症皮质病变的对比度。

阅读:2

Abstract

BACKGROUND AND PURPOSE: Cortical demyelinated lesions are prevalent in multiple sclerosis (MS), associated with disability, and have recently been incorporated into MS diagnostic criteria. Presently, advanced and ultrahigh-field MRIs-not routinely available in clinical practice-are the most sensitive methods for detection of cortical lesions. Approaches utilizing MRI sequences obtainable in routine clinical practice remain an unmet need. We plan to assess the sensitivity of the ratio of T(1) -weighted and T(2) -weighted (T(1) /T(2) ) signal intensity for focal cortical lesions in comparison to other high-field imaging methods. METHODS: 3-Tesla and 7-Tesla MRI collected from 10 adults with MS were included in the study. T(1) /T(2) images were calculated by dividing 3T T(1) -weighted (T(1) w) images by 3T T(2) -weighted (T(2) w) fluid-attenuated inversion recovery images for each participant. A total of 614 cortical lesions were identified using 7T T(2) *w and T(1) w images and corresponding voxels were assessed on registered 3T images. Signal intensities were compared across 3T imaging sequences, including T(1) /T(2) , T(1) w, T(2) w, and inversion recovery susceptibility-weighted imaging with enhanced T(2) weighting (IR-SWIET) images. RESULTS: T(1) /T(2) images demonstrated a larger contrast between median lesional and nonlesional cortical signal intensity (median ratio = 1.29, range: 1.19-1.38) when compared to T(1) w (1.01, 0.97-1.10, p < .002), T(2) w (1.17, 1.07-1.26, p < .002), and IR-SWIET (1.21, 1.01-1.29, p < .03). CONCLUSION: T(1) /T(2) images are sensitive to cortical lesions. Approaches incorporating T(1) /T(2) could improve the accessibility of cortical lesion detection in research settings and clinical practice.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。